# Progress Note 04 — Sick Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Irène Joliot-Curie (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-RB003-SYN-TD
- Date: 1955-10-08
- Fictional facility: St. Posthumous Health Center
- Fictional author: Solène Marchand-Ellis, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Sick Visit
- Services: Problem-oriented office visit, established patient

## Chief complaint

Nausea, two episodes of vomiting, and no bowel movement for four days. **S**

## History of present illness

Mrs. Joliot-Curie called this morning and was seen the same day, on day 11 of her first cycle of azacitidine with venetoclax. For three days she has felt queasy for most of the day, and she vomited twice yesterday, about an hour after her evening meal; the venetoclax tablets had been taken with breakfast and stayed down. She has had no bowel movement for four days and feels bloated, without severe pain. She has checked her temperature twice a day as instructed; the highest was 37.4 °C. She has had no chills, cough, sore throat, mouth sores, painful urination, diarrhea, or rectal pain. Her gums ooze a little when she brushes, and she has new small bruises on her shins. She is drinking about a liter and a half a day. She takes posaconazole, acyclovir, levofloxacin and allopurinol as prescribed. **S**

| Element | Detail |
|---|---|
| Onset | Three days ago |
| Character | Constant nausea; vomiting twice after the evening meal; no stool for four days, with bloating |
| Severity | Moderate; eating about half her usual amount |
| Context | Day 11 of cycle 1 of azacitidine with venetoclax; profound neutropenia expected |
| Associated signs and symptoms | No fever (highest 37.4 °C); gum oozing and new bruises |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; no fever or chills |
| Ears, nose, mouth, and throat | Positive | Gums ooze on brushing; no mouth sores or sore throat |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Positive | Nausea, vomiting twice, constipation and bloating; no abdominal pain, diarrhea, rectal pain or bleeding |
| Genitourinary | Negative | No painful urination |
| Integumentary | Positive | Small bruises on both shins; no rash |
| Neurological | Negative | No headache or confusion |

7 systems reviewed. **S**

## Current medications

- Azacitidine 115 mg (75 mg/m2) under the skin once daily on days 1 to 7 of each 28-day cycle **S**
- Venetoclax 10 mg oral tablet, cycle 1: 10 mg on day 1 and 20 mg on day 2, then two tablets (20 mg) daily with the 50 mg tablet from day 4 (70 mg a day, reduced for posaconazole) **S**
- Venetoclax 50 mg oral tablet, cycle 1: one tablet alone on day 3 (50 mg), then one tablet daily with two 10 mg tablets from day 4 (70 mg a day) **S**
- Posaconazole 100 mg delayed-release tablet, three tablets (300 mg) twice on day 1, then three tablets once daily, as antifungal prophylaxis while neutropenic **S**
- Acyclovir 400 mg oral tablet, one tablet twice daily as herpes simplex and zoster prophylaxis **S**
- Levofloxacin 500 mg oral tablet, one tablet daily while the neutrophil count is below 0.5 **S**
- Allopurinol 300 mg oral tablet, one tablet daily for tumor lysis prophylaxis during cycle 1 **S**
- Ondansetron 4 mg orally disintegrating tablet, one tablet every 8 hours as needed for nausea **S**
- Polyethylene glycol 3350, 17 g powder in a glass of water once daily **S**
- Sennosides 8.6 mg oral tablet, two tablets at bedtime **S**
- Potassium chloride 20 mEq extended-release tablet, one tablet twice daily for three days **S**

## Allergies

- No known allergy **S**

## Objective

BP 106/64 mmHg; pulse 98 bpm; respirations 16/min; temperature 37.2 °C; oxygen saturation 97% on room air; weight 52.4 kg; BMI 19.7 kg/m². All vital signs are synthetic.

White cell count: 0.7 10*3/uL (low); Absolute neutrophil count: 0.1 10*3/uL (low); Hemoglobin: 7.4 g/dL (low); Platelets: 9 10*3/uL (low); Sodium: 137 mmol/L; Potassium: 3.3 mmol/L (low); Creatinine: 0.84 mg/dL; Magnesium: 1.8 mg/dL; QTc (ECG): 446 ms. All results are synthetic.

## Change since baseline

- White cell count: 2.1 10*3/uL (low) at baseline, 0.7 10*3/uL (low) at this visit **S**
- Absolute neutrophil count: 0.6 10*3/uL (low) at baseline, 0.1 10*3/uL (low) at this visit **S**
- Hemoglobin: 8.4 g/dL (low) at baseline, 7.4 g/dL (low) at this visit **S**
- Platelets: 38 10*3/uL (low) at baseline, 9 10*3/uL (low) at this visit **S**
- Sodium: 139 mmol/L at baseline, 137 mmol/L at this visit **S**
- Potassium: 4 mmol/L at baseline, 3.3 mmol/L (low) at this visit **S**
- Creatinine: 0.78 mg/dL at baseline, 0.84 mg/dL at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Tired but alert; temperature 37.2 °C, pulse 98, blood pressure 106/64, oxygen saturation 97% on room air; weight 52.4 kg, down 1.1 kg |
| Mouth | Dry mucous membranes; a few gum petechiae; no ulcers or thrush |
| Skin | Scattered petechiae and small bruises on both shins; injection sites on the abdomen healing |
| Respiratory | Clear to auscultation |
| Abdomen | Mildly distended and soft, with active bowel sounds; no tenderness or guarding. No rectal examination while neutropenic |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Nausea with vomiting and constipation during cycle 1** (R11.2). Nausea and constipation are common with azacitidine and venetoclax. No fever, a soft non-tender abdomen and normal bowel sounds make obstruction or neutropenic enterocolitis unlikely, but she knows to come in at once for pain or fever. Potassium 3.3 mmol/L after vomiting, magnesium 1.8 mg/dL. On posaconazole and levofloxacin, both of which can lengthen the QT interval, the ECG today shows a QTc of 446 ms, so ondansetron can be used with care. **S**
   - Ondansetron 4 mg every 8 hours as needed; no other QT-prolonging antiemetic.
   - Polyethylene glycol 17 g daily and senna two tablets at bedtime; no suppositories or enemas while neutropenic.
   - Potassium chloride 20 mEq twice daily for three days; recheck with the next blood count.
   - Small frequent meals; take venetoclax with breakfast as now.
2. **Acute myeloid leukemia, day 11 of cycle 1** (C92.00). Neutrophils 0.1, hemoglobin 7.4 g/dL and platelets 9 x10^3/uL: the expected nadir. Platelets below 10 call for a prophylactic transfusion, and the hemoglobin with tiredness calls for one unit of red cells. No sign of infection. **S**
   - One unit of irradiated red cells and one dose of irradiated platelets in the infusion unit today.
   - Continue venetoclax 70 mg daily and the prophylactic medicines.
   - Fever plan unchanged: 38.0 °C or more means the emergency department at once.
   - Blood count twice weekly; bone marrow on day 22.

## Medication changes

- Started: Ondansetron 4 mg orally disintegrating tablet, one tablet every 8 hours as needed for nausea **S**
- Started: Polyethylene glycol 3350, 17 g powder in a glass of water once daily **S**
- Started: Sennosides 8.6 mg oral tablet, two tablets at bedtime **S**
- Started: Potassium chloride 20 mEq extended-release tablet, one tablet twice daily for three days **S**

## Guideline basis

- NCCN Clinical Practice Guidelines in Oncology: Acute Myeloid Leukemia, Version 5.2026 (2026), National Comprehensive Cancer Network
- NCCN Clinical Practice Guidelines in Oncology: Prevention and Treatment of Cancer-Related Infections (2026), National Comprehensive Cancer Network
- Carson JL, et al. Red Blood Cell Transfusion: 2023 AABB International Guidelines. JAMA 2023 (PMID 37824153) (2023), Association for the Advancement of Blood and Biotherapies (JAMA)
- Kaufman RM, et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2015 (PMID 25383671) (2015), AABB (Annals of Internal Medicine)
- Hesketh PJ, et al. Antiemetics: ASCO Guideline Update. J Clin Oncol 2020 (PMID 32658626) (2020), American Society of Clinical Oncology

## Follow-up

- Nurse phone call tomorrow. Blood count and potassium in three days. Bone marrow and review on day 22. Go to the emergency department at once for a temperature of 38.0 °C or more, abdominal pain, bleeding that does not stop, or vomiting that prevents taking her tablets. **S**
- Next scheduled visit 1955-10-19: day 22 of cycle 1: bone marrow response, transfusion and infection review, and stopping venetoclax for count recovery. **S**
